UNH Stock: Jefferies Lifts Price Target to $373 as UnitedHealth Surges Over 7%
By TrendSpider Editor
Jefferies analyst David Windley raised his price target on UnitedHealth Group to $373 from $340 while confirming a Buy rating, providing a fundamental tailwind as shares jumped 7.02% to $346.23 on Tuesday. The move comes as UNH trades well off its 52-week low of $234.60 but still meaningfully below
UNH Stock: Jefferies Lifts Price Target to $373 as UnitedHealth Surges Over 7%
Jefferies analyst David Windley raised his price target on UnitedHealth Group to $373 from $340 while confirming a Buy rating, providing a fundamental tailwind as shares jumped 7.02% to $346.23 on Tuesday. The move comes as UNH trades well off its 52-week low of $234.60 but still meaningfully below its 52-week high of $453.50, leaving room for further recovery if momentum holds. The revised target represents roughly 7.7% upside from the current price, signaling Windley sees near-term value even after today's sharp advance.
Key Drivers of the UNH Stock Move
- Main Catalyst: Jefferies analyst David Windley confirmed a Buy rating on UnitedHealth Group and raised his price target to $373 from $340, a $33 increase that reflects growing confidence in the company's outlook and added institutional credibility to the rally.
- Bull Case: The new $373 price target sits above the current price of $346.23, offering approximately 7.7% additional upside from today's close. Combined with a 7.02% single-session gain, UNH is demonstrating meaningful momentum, and the stock remains well below its 52-week high of $453.50, suggesting significant long-term recovery potential if the business fundamentals support it.
- Bear Case: Despite today's gain, UNH is still trading at a steep discount to its 52-week high, implying the stock has faced serious headwinds in recent months. The revised Jefferies target of $373 is a far cry from the $453.50 peak, and with only one analyst action on record today, broader Wall Street conviction behind this move has yet to be confirmed.
The forward setup for UNH is cautiously constructive following today's confirmation from Jefferies. The stock has been under considerable pressure over the past year, having traded as low as $234.60, so today's 7% surge on the back of a single analyst reaffirmation warrants attention from both bulls and bears. Investors will be watching closely for additional analyst actions and upcoming earnings guidance to determine whether this bounce has the fundamental backing needed to sustain a broader recovery toward the $373 target and beyond.
UNH Analyst Ratings and Price Targets
Jefferies analyst David Windley confirmed a Buy rating on UnitedHealth Group today and raised his price target to $373 from a prior target of $340. There were no upgrades or downgrades recorded in today's action. The consensus average price target currently stands at $373, aligning directly with Jefferies' revised figure and suggesting that at the current price of $346.23, the average analyst view implies moderate additional upside.
UNH Seasonality
April has historically been an active month for managed care stocks as the sector digests early-year medical cost trend data and prepares for Q1 earnings season, making analyst target revisions this time of year a closely watched signal. A Buy confirmation in mid-to-late April, when sector sentiment often resets around earnings, can carry added weight for short-term momentum traders and institutional positioning.
UNH Relative Performance
UNH's 7.02% single-session gain stands out sharply relative to broader market benchmarks, making it one of the stronger large-cap performers on the session. Trading at $346.23 against a 52-week range of $234.60 to $453.50, UNH sits in the lower half of its annual range, underperforming its own historical highs by a wide margin even after today's advance. If the broader health insurance sector is participating in today's move, UNH's outsized gain would suggest it is leading peers rather than simply moving with the group.